Tobacco Pulse Surveys: Q2 2026

Share on twitter
Share on email
Share on whatsapp
Share on linkedin

Every Sunday, we run a poll on the hottest subject in the Tobacco Industry. Hundreds of our Twitter/X followers vote, offering a collective wisdom on the subject matter or an immediate pulse on the market/industry developments.

Results of the Sunday polls:

May 31, 2026

What will you scrutinize first & foremost in British American Tobacco (BAT) H1 Trading Update (June 2, Tuesday)?

– New category performance (VELO, VUSE, glo): 52%

– FY26 guidance: 29%

– Capital allocation: 14%

– U.S. cigarette volume/pricing: 5%

May 24, 2026

Which tobacco major will deliver the best total shareholder return (share price appreciation + dividends) over the next 12 months?

– British American Tobacco: 54%

– Philip Morris International: 19%

– Altria: 15%

– Imperial Brands: 12%

May 17, 2026

At $68, Altria shares are…

– Fairly valued: 62% (+16pp)

– Undervalued: 23% (-20pp)

– Overvalued: 15% (+3pp)

May 10, 2026

At $68, Altria shares are…

– Fairly valued: 46% (+2pp)

– Overvalued: 34% (-5pp)

– Undervalued: 20% (+3pp)

May 3, 2026

At $166, Philip Morris International (PMI) shares are…

– Fairly valued: 53% (+8pp)

– Overvalued: 27% (-17pp)

– Undervalued: 20% (+9pp)

April 26, 2026

Why Altria is the best performing major tobacco stock in 2026?

– Cheap → catch-up trade: 46%

– Ultimate safe haven: 23%

– Improved fundamentals: 15%

– Market mispricing: 15%

April 19, 2026

Which tobacco company would you never invest in – no matter how attractive the valuation?

– Altria: 39%

– Japan Tobacco: 34%

– Imperial Brands: 14%

– British American Tobaco: 13%

Result: Altria leads at 39%, followed by Japan Tobacco (34%) in “never invest” votes, with no change among the most avoided names. Notably, Imperial drops 13pp to 14%, while BAT remains the least avoided at 13% despite a 3pp increase

April 12, 2026

What will you scrutinize first & foremost in Philip Morris International Q1 2026 results (April 22)?

– ZYN volume/pricing: 47%

– Financials/Guidance (Revenue, EPS, operating margin, adjustments): 22%

– Heated tobacco growth: 19%

– IQOS USA update: 13%

April 5, 2026

The U.S. FDA’s slower, more cautious review of nicotine pouch applications is _____ for major tobacco companies.

– Neutral: 32%

– Negative: 29%

– To early to tell: 21%

– Positive: 18%

Tobacco Pulse Surveys: Q1 2026

Tobacco Pulse Surveys: Q4 2025

Tobacco Pulse Surveys: Q3 2025

Tobacco Pulse Surveys: Q2 2025

Tobacco Pulse Surveys: Q1 2025

Tobacco Pulse Surveys: Q4 2024

Tobacco Pulse Surveys: Q3 2024

Tobacco Pulse Surveys: Q2 2024

Tobacco Pulse Surveys: Q1 2024

Tobacco Pulse Surveys: Q4 2023

Tags:

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address